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Background: As the number of studies on the future situation of sickness absentees still is very limited, we aimed
to investigate the association between number of sick-leave days and future all-cause and cause-specific mortality
among women and men.
Methods: A cohort of 2 275 987 women and 2 393 248 men, aged 20–64 years in 1995 was followed 1996–2006
with regard to mortality. Data were obtained from linked authority-administered registers. The relative risks (RR) and
95% confidence intervals (CI) of mortality with and without a 2-year wash-out period were estimated by multivariate
Poisson regression analyses. All analyses were stratified by sex, adjusting for socio demographics and inpatient care.
Results: A gradually higher all-cause mortality risk occurred with increasing number of sick-leave days in 1995,
among both women (RR 1.11; CI 1.07-1.15 for those with 1–15 sick-leave days to RR 2.45; CI 2.36-2.53 among those
with 166–365 days) and men (RR 1.20; CI 1.17-1.24 to RR 1.91; CI 1.85-1.97). Multivariate risk estimates were comparable
for the different causes of death (circulatory disease, cancer, and suicide). The two-year washout period had only a
minor effect on the risk estimates.
Conclusion: Even a low number of sick-leave days was associated with a higher risk for premature death in the following
11 years, also when adjusting for morbidity. This was the case for both women and men and also for cause-specific
mortality. More knowledge is warranted on the mechanisms leading to higher mortality risks among sickness absentees,
as sickness certification is a common measure in health care, and most sick leave is due to diagnoses you do not
die from.
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Today, the number of studies on risk factors for sickness
absence has increased much, however, the number of
studies on the future situation of sickness absentees is
still very limited [1]. Most of the few studies so far con-
ducted have focused on to what extent sickness absence
can predict all-cause and cause-specific mortality in oc-
cupational [2,3] or population-based cohorts [2-8], with
different follow-up periods. The risk of premature death
varies somewhat with used measures of sickness absence,* Correspondence: emma.bjorkenstam@ki.se
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article, unless otherwise stated.nevertheless, an excess rate of premature death was found
in all studies [2-10]. There is a need to test those results in
a larger, population-based cohort with a long follow-up
period.
In welfare countries, to sickness certify patients is a
common measure in healthcare, why more knowledge is
warranted on associations between sickness absence and
premature death. For instance, it is important to disen-
tangle to what extent excess risks merely are due to a
greater occurrence of morbidity among people who are
sickness absent. There are several ways to measure mor-
bidity, in research often self-reports are used [5,6,11].
Data on inpatient care, that is, being hospitalized, could
be considered as data on more severe morbidity as wellntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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and therefore more valid. Also, the association between
sickness absence and subsequent deaths might be due to
the very disease that leads to the sickness absence. To
account for that when trying to disentangle the associa-
tions between sickness absence and morbidity, sometimes
a so called wash-out period is introduced, to exclude all
deaths occurring in a near time frame, e.g., using a two-
year wash out period [5].
Moreover, a great number of studies have shown gender
differences in morbidity, in sickness absence, as well as in
mortality [12-15]. There are several reasons to believe that
the mechanisms leading to morbidity, to sickness absence,
and to mortality might differ to some extent between the
genders and that such aspects might not be visible when
combining data for women and men, why gender-specific
analyses are recommended [16-20].
The aim of this study was to investigate the associa-
tions between number of sick-leave days and future all-
cause and cause-specific mortality among women and
men, adjusting for morbidity and socioeconomic status,
and also taking into account a two-year wash-out period
for the relative risk of mortality.
Methods
Study population
A population-based prospective cohort study was con-
ducted with an eleven-year follow up.
The cohort included all individuals aged 20–64 years,
registered in Sweden on 31 December 1994 and 1995,
and not on disability or old-age pension in 1995 (N = 4
669 235, 49% women). The cohort was identified from
Statistics Sweden’s integrated population-based database
for labor-market research (LISA). From this database
also information regarding sick leave, disability pension,
and other sociodemographic factors in 1995 was obtained.
Further, date and cause of death was obtained from the
Cause of Death Register, held by the National Board of
Health and Welfare. The National Patient Register, also
held by the National Board of Health and Welfare, was
used to obtain information on inpatient care.
Variables
All sick-leave days in 1995 reimbursed by the National
Social Insurance Agency were included and categorized
into five groups; 0 days (reference category), 1-15 days,
16-75 days, 76-165 days, and 166-365 days. From the
age of 16 years, all Swedish residents with income from
work, unemployment benefits, or student benefits are
covered by the national sickness absence insurance re-
gime and can be sickness absent with benefits if unable
to work due to disease or injury. Benefits amount up to
80% of lost income. The first day of a sick-leave spell is
a qualifying day, without any benefits. The first sevendays can be self-certified; thereafter a physician certifi-
cate is needed. For those employed, the employer usually
paid for the first 14 days of the sick-leave spell; those
days are not registered in LISA and thus not included in
this study. Unemployed people, if their morbidity lead to
that they could not seek work, had sickness benefits paid
by the Social Insurance Agency from the second day of
the sick-leave spell. This means that for them also the
shorter sick-leave spells were included. For most of the
absentees, the category 1-15 days means that they had
been sickness absent for 15-30 days.
Information about inpatient care was obtained for the
years 1990-95, excluding hospitalization due to child-
birth. The median number of days of inpatient care for
those who were hospitalized was 5 days for the six-year
period. Inpatient care days were categorized as; 0 days,
1-5 days, and more than 5 days.
In the analyses, age was used as a continuous variable
and educational level was categorized into four groups:
elementary school (9 years or less of schooling), second-
ary (10-12 years), university level (more than 12 years),
or information missing. Type of place of residence was
divided into a) large cities (Stockholm, Göteborg, and
Malmö), b) middle-sized cities: places with more than 90
000 residents within 30 km from the municipal center,
and c) rural municipalities (all other areas). Region of
birth was categorized into Sweden, other Nordic country,
other EU25, and other countries.
As outcome measure, we studied all-cause mortality for
the years 1996-2006 as well as cause-specific mortality
from circulatory diseases, cancer, and suicide, respectively.
Statistical analyses
Multivariate analyses were conducted by Poisson regres-
sion with mortality as the dependent variable. The relative
risk (RR) of mortality was estimated with 95% confidence
interval (CI). Follow-up time was assessed by adding up
the months the individuals were alive and residents of
Sweden during the 11-years follow-up period 1996–2006.
The associations between sick leave in 1995 and mortality
were analyzed in five regression models. The reference
group comprised individuals without sick-leave days in
1995. In model I, adjustments were made for age. In a sec-
ond model (model II) we made additional adjustments for
socio-demographic factors; i.e. educational level, type of
place of residence, and region of birth. In model III, we
adjusted for inpatient care in 1990-1995. Model IV in-
cluded all covariates. In a fifth model, as an attempt to
rule out that observed associations are not mainly due to
an excess rate of sick leave shortly before death, a washout
period of two years was used, that is, follow-up started in
the third year after baseline (1998-2006). This included
those who still lived 1 January 1998, conducting the same
adjustment as in Model IV. Statistical analyses were
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9.3. In accordance with the aim, all analyses were
stratified by sex.
The project was approved of by the Regional Ethical
Review Board of Stockholm (dnr 2007/762-31).
Results
In this cohort of 4.7 million people of working ages, the
mean age was about 40 years both among women and
men. A slightly higher proportion of the men than the
women had lower educational level (Table 1). About
70% of the women and 78% of the men had no inpatient
care at all during 1990–1995. A higher rate of the womenTable 1 Characteristics for the cohort of 4 669 235 women an









Medium 1 145 377
High 641 030
Missing data 20 547
Type of place of residency
Rural/small 629 223
Middle-sized city 820 991
Large 825 773
Region of birth
Sweden 1 990 505
Other Nordic 100 027
EU25 49 742
Other country 135 611
Missing data 102
No. of sick-leave days2 in 1995





No. of days with hospital in patient care in 1990-1995
0 1 588 412
1-5 343 370
6+ 344 205
1Low = ≤9 years; Medium = 10–12 years; High = 13+ years;
2Days reimbursed by the Social Insurance Agency, usually from the 15th day of a sichad had longer hospitalization. Also, a higher rate of
the women had been sickness absent in 1995 and the
mean number of sick-leave days during 1995 was
10.6 days in women and 8.0 days in men (not shown in
table).
The relative risks (RR) of all-cause mortality dis-
played a gradual increase with increasing number of
sick-leave days in 1995 among both women and men
(Table 2). In the age-adjusted models, women and men
with most sick-leave days (166–365 days), had more
than tripled mortality risks; women RR 3.48; 95% CI 3.37-
3.60 and men RR 3.29; CI 3.20-3.39 in comparison with
women and men, respectively, without any sick-leave daysd men aged 20–64 and living in Sweden in 1995
275 987, 48.7%) Men (n = 2 393 248, 51.3%)
% n %
38.3 915 795 38.3
23.9 573 897 24.0
24.1 590 805 24.7
13.6 312 751 13.1
20.6 580 188 24.2
50.3 1 181 081 49.4
28.2 605 739 25.3
0.9 26 240 1.1
27.6 685 660 28.6
36.1 867 944 36.3
36.3 839 644 35.1
87.5 2 103 036 87.9
4.4 85 754 3.6
2.2 50 887 2.1
6.0 153 363 6.4
0.0 208 0.0
84.3 2 135 089 89.2
6.1 96 883 4.0
5.5 88 137 3.7
1.9 31 834 1.3
2.1 41 305 1.7
69.8 1 872 333 78.2
15.1 302 106 12.6
15.1 218 809 9.1
k-leave spell.
Table 2 Relative risk (RR) for all-cause mortality among women and men on sick leave with adjustments in four models
and in a fifth model with two years wash-out period
Sex Sick-leave days1 Number of deaths Model I Model II Model III Model IV Model V
Women 0 35 833 1 (REF) 1 (REF) 1 (REF) 1 (REF) 1 (REF)
1-15 3 086 1.24 (1.19-1.28) 1.23 (1.18-1.27) 1.11 (1.07-1.16) 1.11 (1.07-1.15) 1.11 (1.07-1.15)
16-75 4 139 1.62 (1.57-1.67) 1.61 (1.56-1.66) 1.28 (1.24-1.32) 1.27 (1.23-1.32) 1.25 (1.21-1.30)
76-165 2 242 2.42 (2.32-2.53) 2.39 (2.29-2.50) 1.81 (1.73-1.89) 1.79 (1.71-1.87) 1.60 (1.52-1.68)
166-365 3 878 3.48 (3.37-3.60) 3.38 (3.27-3.50) 2.50 (2.42-2.59) 2.45 (2.36-2.53) 1.97 (1.89-2.05)
Men 0 63 407 1 (REF) 1 (REF) 1 (REF) 1 (REF) 1 (REF)
1-15 4 556 1.47 (1.42-1.51) 1.41 (1.37-1.45) 1.24 (1.21-1.28) 1.20 (1.17-1.24) 1.20 (1.16-1.24)
16-75 5 990 1.93 (1.88-1.99) 1.84 (1.80-1.89) 1.42 (1.38-1.46) 1.37 (1.33-1.41) 1.33 (1.29-1.37)
76-165 3 192 2.66 (2.56-2.75) 2.52 (2.44-2.62) 1.71 (1.65-1.78) 1.65 (1.59-1.71) 1.53 (1.46-1.59)
166-365 5 347 3.29 (3.20-3.39) 3.08 (3.00-3.17) 2.00 (1.95-2.07) 1.91 (1.85-1.97) 1.71 (1.65-1.77)
1Days reimbursed by the Social Insurance Agency, usually from the 15th day of a sick-leave spell.
Model I: adjustment for age.
Model II: adjustment for age and education, type of place of residence, and region of birth.
Model III: adjustment for age, number of days in hospital (categorized).
Model IV: adjustment for age, number of days in hospital (categorized), education, type of place of residence, and region of birth.
Model V: model IV with two years wash-out period.
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justments for socio-demographics did not substantially
change the estimates. When inpatient care was taken into
account (model III), the excess risks generally decreased,
but the clear gradients remained. In the fully adjusted
models (model IV), the risks decreased further. Using a
“wash-out”-period of two years in model V, e.g., starting the
follow-up 1998, decreased the excess risk to some extent
regarding death risks associated with number of sick-leave
days. However, evident associations remained with a pro-
nounced gradient.
The RRs of mortality due to circulatory diseases are
presented in Table 3. Although risk estimates were lower
compared to RRs of all-cause mortality, a gradualTable 3 Relative risk (RR) of premature death from circulatory
adjustments in four models and in a fifth model with two yea
Sex Sick-leave days1 Number of deaths Model I
Women 0 6 366 1 (REF)
1-15 520 1.20 (1.10-1.31)
16-75 697 1.54 (1.42-1.67)
76-165 319 1.92 (1.72-2.15)
166-365 552 2.74 (2.51-2.99)
Men 0 19 632 1 (REF)
1-15 1 331 1.38 (1.31-1.46)
16-75 1 751 1.78 (1.70-1.87)
76-165 866 2.24 (2.09-2.40)
166-365 1 526 2.90 (2.75-3.05)
1Days reimbursed by the Social Insurance Agency, usually from the 15th day of a sic
Model I: adjustment for age.
Model II: adjustment for age and education, type of place of residence, and region
Model III: adjustment for age, and number of days in hospital (categorized).
Model IV: adjustment for age, number of days in hospital (categorized), education,
Model V: model IV with two years wash-out period.increase with increasing number of sick-leave days
among both women and men emerged. In a similar way,
the risk estimates decreased after adjusting for several
potential confounders. Even in the fully adjusted model
(model IV), both women and men with more than 75
sick-leave days had a nearly 50% higher risk of prema-
ture death due to a circulatory disease during the follow-
up period than women without such sick-leave days.
Introducing a wash-out period did not change the ad-
justed RRs of premature death from circulatory diseases.
The associations of number of sick-leave days with
subsequent cancer-related death were similar (Table 4).
Both women and men with at least one sick-leave day
had a higher risk of premature death from cancerdiseases among women and men on sick leave with
rs wash-out period
Model II Model III Model IV Model V
1 (REF) 1 (REF) 1 (REF) 1 (REF)
1.19 (1.08-1.30) 1.08 (0.99-1.19) 1.07 (0.98-1.17) 1.11 (1.01-1.22)
1.52 (1.41-1.64) 1.26 (1.16-1.37) 1.25 (1.16-1.36) 1.28 (1.18-1.40)
1.89 (1.69-2.11) 1.43 (1.27-1.60) 1.42 (1.26-1.59) 1.40 (1.23-1.58)
2.59 (2.37-2.82) 1.87 (1.71-2.05) 1.80 (1.64-1.97) 1.84 (1.67-2.03)
1 (REF) 1 (REF) 1 (REF) 1 (REF)
1.32 (1.25-1.39) 1.18 (1.11-1.24) 1.13 (1.07-1.20) 1.15 (1.08-1.22)
1.69 (1.61-1.78) 1.31 (1.24-1.38) 1.26 (1.19-1.32) 1.28 (1.21-1.35)
2.12 (1.98-2.27) 1.41 (1.32-1.52) 1.36 (1.26-1.45) 1.37 (1.27-1.48)
2.69 (2.56-2.84) 1.73 (1.63-1.83) 1.63 (1.54-1.72) 1.62 (1.53-1.72)
k-leave spell.
of birth.
type of place of residence, and region of birth.
Table 4 Relative risk (RR) of premature death from cancer diagnoses among women and men on sick leave with
adjustments in four models and in a fifth model with two years wash-out period
Sex Sick-leave days1 Number of deaths Model I Model II Model III Model IV Model V
Women 0 21 833 1 (REF) 1 (REF) 1 (REF) 1 (REF) 1 (REF)
1-15 1774 1.17 (1.12-1.23) 1.16 (1.11-1.22) 1.08 (1.03-1.13) 1.07 (1.02-1.13) 1.08 (1.02-1.13)
16-75 2318 1.49 (1.43-1.55) 1.48 (1.42-1.55) 1.19 (1.14-1.25) 1.19 (1.14-1.24) 1.14 (1.09-1.20)
76-165 1347 2.38 (2.25-2.52) 2.37 (2.24-2.50) 1.91 (1.80-2.02) 1.90 (1.80-2.01) 1.60 (1.50-1.71)
166-365 2331 3.42 (3.27-3.57) 3.38 (3.24-3.53) 2.81 (2.69-2.94) 2.78 (2.65-2.90) 1.93 (1.82-2.04)
Men 0 24 101 1 (REF) 1 (REF) 1 (REF) 1 (REF) 1 (REF)
1-15 1461 1.24 (1.17-1.30) 1.21 (1.15-1.28) 1.14 (1.08-1.20) 1.11 (1.06-1.18) 1.10 (1.04-1.16)
16-75 1937 1.60 (1.53-1.68) 1.57 (1.50-1.64) 1.34 (1.28-1.40) 1.31 (1.25-1.37) 1.20 (1.13-1.26)
76-165 1089 2.28 (2.15-2.43) 2.23 (2.10-2.37) 1.76 (1.66-1.88) 1.72 (1.62-1.83) 1.40 (1.30-1.51)
166-365 1813 2.79 (2.66-2.93) 2.70 (2.57-2.83) 2.19 (2.08-2.30) 2.12 (2.01-2.23) 1.59 (1.49-1.69)
1Days reimbursed by the Social Insurance Agency, usually from the 15th day of a sick-leave spell.
Model I: adjustment for age.
Model II: adjustment for age and education, type of place of residence, and region of birth.
Model III: adjustment for age, and number of days in hospital (categorized).
Model IV: adjustment for age, number of days in hospital (categorized), education, type of place of residence, and region of birth.
Model V: model IV with two years wash-out period.
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contrary to the analyses on death from circulatory dis-
eases, the wash-out period decreased the adjusted RRs
of death.
The analyses presented in Table 5 show that sick leave
was associated with a higher risk of suicide in both
women and men. The RR for suicide increased in a
graded fashion with more sick-leave days in both women
and men, even after adjustment for several potential
confounding factors. Adjusting for inpatient care de-
creased the estimates significantly for both sexes. Taking
a wash-out period of two years into consideration de-
creased the estimates somewhat for both women and
men.Table 5 Relative risk (RR) of premature death from suicide am
four models and in a fifth model with two years wash-out pe
Sex Sick-leave days1 Number of deaths Model I
Women 0 1 461 1 (REF)
1-15 163 1.54 (1.31-1.81)
16-75 256 2.65 (2.32-3.03)
76-165 158 4.77 (4.05-5.62)
166-365 257 7.13 (6.24-8.15)
Men 0 4 768 1 (REF)
1-15 415 1.91 (1.73-2.12)
16-75 497 2.54 (2.32-2.79)
76-165 295 4.22 (3.75-4.75)
166-365 439 4.99 (4.52-5.50)
1Days reimbursed by the Social Insurance Agency, usually from the 15th day of a sic
Model I: adjustment for age.
Model II: adjustment for age and education, type of place of residence, and region
Model III: adjustment for age, and number of days in hospital (categorized).
Model IV: adjustment for age, number of days in hospital (categorized), education,
Model V: model IV with two years wash-out period.Discussion
The results from this longitudinal study of 4.7 million
women and men from the general population of working
ages clearly demonstrated a gradual increase of all-cause
and cause-specific premature death with increasing
number of sick-leave days. Part of the mortality differ-
ences in the multivariate analyses was accounted for by
differences in age, socio demographics, and particularly
by morbidity, indicated by inpatient care. Results were
similar for women and men. The two-year washout
period had only a minor effect on the risk estimates.
Individuals having been sickness absent, also only for a
few weeks, were found to have a higher risk for prema-
ture death, despite the fact that even individuals in theong women and men on sick leave, with adjustments in
riod
Model II Model III Model IV Model V
1 (REF) 1 (REF) 1 (REF) 1 (REF)
1.52 (1.29-1.79) 1.30 (1.11-1.53) 1.29 (1.10-1.52) 1.27 (1.06-1.52)
2.60 (2.28-2.97) 1.85 (1.61-2.13) 1.84 (1.60-2.11) 1.70 (1.46-1.99)
4.64 (3.93-5.47) 2.55 (2.14-3.02) 2.51 (2.12-2.99) 2.38 (1.95-2.89)
6.77 (5.92-7.74) 2.90 (2.50-3.36) 2.83 (2.44-3.28) 2.64 (2.23-3.13)
1 (REF) 1 (REF) 1 (REF) 1 (REF)
1.80 (1.62-1.99) 1.54 (1.39-1.70) 1.47 (1.33-1.62) 1.46 (1.31-1.64)
2.36 (2.15-2.59) 1.69 (1.53-1.86) 1.62 (1.47-1.78) 1.60 (1.44-1.78)
3.91 (3.47-4.40) 2.27 (2.01-2.57) 2.18 (1.93-2.46) 2.16 (1.88-2.48)
4.57 (4.14-5.04) 2.28 (2.05-2.54) 2.20 (1.98-2.45) 1.97 (1.74-2.24)
k-leave spell.
of birth.
type of place of residence, and region of birth.
Björkenstam et al. BMC Public Health 2014, 14:733 Page 6 of 8
http://www.biomedcentral.com/1471-2458/14/733reference group might have been sickness absent later
on, e.g., the year following the year of observation and
despite the very long follow-up time of 11 years. More
knowledge is warranted on these associations, regarding
e.g. in different populations, time periods, and for differ-
ent diagnoses. It might be argued that an association be-
tween sickness absence and premature death is expected
as those on sick leave are that due to the underlying
morbidity. However, the ill-health content of sick leave
has often been questioned in the general debate [21,22].
Also, most sickness absences are due to musculoskeletal
disorders – disorders that hardly ever are a cause of
death, or due to minor mental disorders, which also very
seldom are a cause of death with exception of suicide
[13,21,23]. Many of the very short sick-leave spells are
due to upper respiratory infections [13]. However, few of
those are included in our data base due to the fact that
the first 14 days of a sick-leave spell are paid by the em-
ployer. The main causes of death in Sweden as well as in
other Western countries are circulatory disease and can-
cer – however, those diagnoses only stand for a few per-
centages of the sick-leave diagnoses [24].
Other hypotheses of the identified associations are that
sick leave might be a marker of other factors, or that
sick leave per se is a risk factor for morbidity or mortal-
ity. Different possible negative consequences of being
sickness absent have been described in the literature, e.g.
negative changes of life style (alcohol, exercise, diet, to-
bacco), of social interactions, of economy or work car-
rier, of the prognosis of the disease underlying the
absence or of other diseases (e.g. depression) [1,25].
The higher risk of premature death with increasing
number of sick-leave days is in line with previous studies
[4,5,7,9]. As all these studies have somewhat different
ways of defining sickness absence, the results from these
studies cannot easily be compared. Still, findings from
our study based on a very large population-based data-
base, point in the same direction as previous studies and
warrants follow ups using more specified research
questions.
In our study, socio-demographic factors did not seem
to explain much of the higher mortality risks. There is
massive evidence on the associations between socio-
economic status and mortality [12,26,27]. We used edu-
cational level as a proxy of socioeconomic status rather
than income, in the attempt not to introduce an un-
necessary gender bias (as women get less paid and a lar-
ger rate of women works part time). In general, people
of lower socioeconomic status have higher risk for sick-
ness absence [13,28], however, possible effects of sick-
ness absence regarding premature death do not seem to
differ between socioeconomic groups. The same can be
said about gender; women have higher risks for becom-
ing sickness absent; however, we in general found nogender differences regarding premature death among
sickness absentees. It seems as the possible negative ‘ef-
fects’ of sickness absence do not vary between genders
or socioeconomic groups.
Our results clearly indicate a higher RR for premature
death due to circulatory diseases among women and
men on sick leave, especially for those who had more
than 15 sick-leave days in 1995, that is, mainly more
than one months’ sick leave. This is in line with two pre-
vious studies based on occupational groups, finding that
long-term sick leave is a risk factor for cardiovascular
mortality [3,7]. Our results also correspond with another
finding from these two studies [3,7], namely that sick
leave was associated with cancer-related mortality.
We found an elevated suicide risk in women and men
who had been on sick leave. The suicide risk increased
in a graded manner as the number of sick-leave days in-
creased, for both women and men. A few other studies
have also found sick leave to be a risk factor for suicide
[7,29,30]. In one of them, a case–control study with a
lower number of women, sickness absence was a risk
factor only for men [30]. It is well known that, in most
Western countries, men have higher suicide rates than
women [31,32]. However, here we studied the relative
risks for suicide among sickness absent women and
men, respectively, and found that those did not differ
much between the genders.
Strengths
The strengths of this study are the population-based,
prospective cohort design, with a very long follow-up
time, the very large number of included individuals, the
high quality of the nationwide register data, e.g. regard-
ing completeness and validity [33,34] and that there was
no loss to follow up. The size of the cohort (4.7 millions)
also provided sufficient power for gender-stratified ana-
lyses regarding rare outcomes such as suicide. As both
the exposure and outcome were based on register data,
there was no recall bias. Other strengths are that most
of the sick-leave days as well as all hospitalizations were
certified by a physician and that all individuals not at
risk for sickness absence in 1995 were excluded, that is,
those on disability pension.
Limitations
The available information about health conditions was
limited to morbidity leading to hospital care, which
means that we were not able to account for all types of
morbidity in the analyses. Hence, part of the higher risks
may have been attributed to other types of impaired
health among sick-listed people. On the other hand, it
can be seen as an advantage that only the more severe
morbidity was adjusted for, especially as morbidity sel-
dom is accounted for in studies of associations between
Björkenstam et al. BMC Public Health 2014, 14:733 Page 7 of 8
http://www.biomedcentral.com/1471-2458/14/733sick leave and premature deaths. That shorter sick-leave
spells (<14 days) for employees could not be included
can also be regarded both as a limitation and a strength.
However, other studies have shown associations also
with short-term sickness absence [7,10], which means
that we rather have an under- than an over-estimation
of results. Another limitation is that we could not ex-
clude the sick-leave days from sick-leave spells shorter
than 15 days - that is, days generally generated by un-
employed people who had their sick-leave spells reim-
bursed by the Social Insurance Agency already from day
2. This means that there is an overrepresentation of un-
employed among those in the category of 1-15 sick-leave
days. However, most sickness absentees are working,
and some of the unemployed do not have unemploy-
ment benefits- due to not having had a paid work lasting
for 12 months or due to having been unemployed for
too long time. This means that both in the reference
group and in the group of fewer sick-leave days, there
was a slight overrepresentation of unemployed. Future
studies are needed to gain more knowledge on this. Despite
the considerably large dataset including a number of im-
portant confounders, information on some potential con-
founders such as self-reports on health behavior including
smoking and alcohol consumption could have been of im-
portance. Moreover, the study was carried out using the
year 1995 as baseline. Future studies are warranted to in-
clude cohorts based on other time periods and using other
measures of sickness absence [35,36]. Moreover, the use of
a two-year washout period can be questioned - both as be-
ing too long and as being too short - the effect of using dif-
ferent wash-out periods needs to be investigated in more
detailed studies.Conclusions
There was a clear association between sickness absence
and all-cause and cause-specific mortality, even for a
relatively short number of sick-leave days, also when
adjusting for morbidity. Moreover, the higher risks were
about the same for women and men, although there are
higher risks for women to become sickness absent. As
sickness certification of patients is common in health
care, more knowledge on possible mechanisms behind
the results is warranted.Competing interests
The authors declare that they have no competing interests.Author’s contribution
EMR and KA originated the idea. GWR analysed the data in consultation with
KA, CL, and EMR. EB wrote the first and subsequent drafts of the manuscript,
with important intellectual input from all the co-authors. All authors contributed
in designing the study and to the interpretation of the results and to the
writing and approval of the final article.Funding
This study was financially supported by the Swedish Ministry of Health and
Welfare, the Research Council of Working life and Social Sciences, and the
Swedish Research Council (dnr S2009/2185/SF). EMR is the recipient of the
Associate professorship grant from the Swedish Research Council (dnr 522-
2010-2683).
Author details
1Department of Clinical Neuroscience, Division of Insurance Medicine,
Karolinska Institutet, Berzelius väg 3, Stockholm SE-171 77, Sweden. 2National
Board of Health and Welfare, Stockholm, Sweden.
Received: 27 March 2014 Accepted: 10 July 2014
Published: 18 July 2014
References
1. Vingård E, Alexanderson K, Norlund A: Swedish Council on Technology
Assessment in Health Care (SBU). Chapter 9. Consequences of being on
sick leave. Scand J Public Health 2004, 32(63):207–215.
2. Ferrie JE, Vahtera J, Kivimaki M, Westerlund H, Melchior M, Alexanderson K,
Head J, Chevalier A, Leclerc A, Zins M, Goldberg M, Singh-Manoux A:
Diagnosis-specific sickness absence and all-cause mortality in the GAZEL
study. J Epidemiol Community Health 2009, 63(1):50–55.
3. Head J, Ferrie JE, Alexanderson K, Westerlund H, Vahtera J, Kivimaki M:
Diagnosis-specific sickness absence as a predictor of mortality: the
Whitehall II prospective cohort study. BMJ 2008, 337:a1469.
4. Gjesdal S, Ringdal PR, Haug K, Maeland JG, Vollset SE, Alexanderson K:
Mortality after long-term sickness absence: prospective cohort study.
Eur J Public Health 2008, 18(5):517–521.
5. Kivimaki M, Head J, Ferrie JE, Shipley MJ, Vahtera J, Marmot MG: Sickness
absence as a global measure of health: evidence from mortality in the
Whitehall II prospective cohort study. BMJ 2003, 327(7411):364.
6. Kivimaki M, Head J, Ferrie JE, Singh-Manoux A, Westerlund H, Vahtera J,
Leclerc A, Melchior M, Chevalier A, Alexanderson K, Zins M, Goldberg M:
Sickness absence as a prognostic marker for common chronic condi-
tions: analysis of mortality in the GAZEL study. Occup Environ Med 2008,
65(12):820–826.
7. Vahtera J, Pentti J, Kivimaki M: Sickness absence as a predictor of
mortality among male and female employees. J Epidemiol Community
Health 2004, 58(4):321–326.
8. Wang M, Alexanderson K, Runeson B, Head J, Melchior M, Perski A,
Mittendorfer-Rutz E: Are all-cause and diagnosis-specific sickness
absence, and sick-leave duration risk indicators for suicidal behaviour?
A nationwide register-based cohort study of 4.9 million inhabitants of
Sweden. Occup Environ Med 2014, 71(1):12–20.
9. Lund T, Kivimaki M, Christensen KB, Labriola M: Socio-economic differences
in the association between sickness absence and mortality: the
prospective DREAM study of Danish private sector employees. Occup
Environ Med 2009, 66(3):150–153.
10. Marmot M, Feeney A, Shipley M, North F, Syme SL: Sickness absence as a
measure of health status and functioning: from the UK Whitehall II
study. J Epidemiol Community Health 1995, 49(2):124–130.
11. Alexanderson K, Kilbom A, Messing K, Bildt Thorbjörnsson C: Measuring
health. Indicators for working women. In Women’s health at work.
Stockholm: National Institute for Working Life; 1998.
12. Marmot M: The status syndrome. How social standing affects our health and
longevity. New York: Time Books, Henry Holt and Company, LLC; 2004.
13. Alexanderson K, Norlund A: Swedish Council on Technology Assessment
in Health Care (SBU). Chapter 1. Aim, background, key concepts,
regulations, and current statistics. Scand J Public Health 2004, 32(63):12–30.
14. National Board of Health and Welfare: Health in Sweden: The national public
health report 2012. Scand J Public Health Suppl 2012, 40(9 suppl):293.
15. OECD: Sickness, disability and work: Breaking the barriers. Paris, France: OECD;
2009.
16. Ahlgren C, Hammarström A: Back to work? Gendered experiences of
rehabilitation. Scand J Public Health 2000, 28(2):88–94.
17. Ostlin P, Danielsson M, Diderichsen F, Härenstam A, Lindberg G (Eds):
Gender inequalities in health: a Swedish perspective. Cambridge, USA: Harvard
University Press; 2002.
18. Sen G, Ostlin P (Eds): Gender Equity in Health. The Shifting Frontiers of
Evidence and Action. New York: Routledge; 2010.
Björkenstam et al. BMC Public Health 2014, 14:733 Page 8 of 8
http://www.biomedcentral.com/1471-2458/14/73319. Östlund G, Cedersund E, Hensing G, Alexanderson K: Domestic strain: a
hindrance in rehabilitation? Scand J Caring Sci 2004, 18:49–56.
20. Mastekaasa A: Sickness absence in female- and male-dominated
occupations and workplaces. Soc Sci Med 2005, 60(10):2261–2272.
21. Waddell G (Ed): The back pain revolution. 2nd edition. Edinburgh: Churchill
Livingstone; 2004.
22. Waddell G, Burton K: Is work good for your health and well-being?. London:
TSO; 2006.
23. Hansson T, Jensen I: Swedish Council on Technology Assessment in
Health Care (SBU). Chapter 6. Sickness absence due to back and neck
disorders. Scand J Public Health Suppl Review 2004, 32(63 suppl):109–151.
24. Perk J, Alexanderson K: Swedish Council on Technology Assessment in
Health Care (SBU). Chapter 8. Sick leave due to coronary artery disease
or stroke. Scand J Public Health 2004, 32(63):181–206.
25. Floderus F, Göransson S, Alexanderson K, Aronsson G: Self-estimated life
situation in patients on long-term sick leave. J Rehabil Med 2005, 37:291–299.
26. Geyer S, Hemstrom O, Peter R, Vagero D: Education, income, and
occupational class cannot be used interchangeably in social
epidemiology. Empirical evidence against a common practice. J Epidemiol
Community Health 2006, 60(9):804–810.
27. Gallo V, Mackenbach JP, Ezzati M, Menvielle G, Kunst AE, Rohrmann S, Kaaks
R, Teucher B, Boeing H, Bergmann MM, Tjønneland A, Dalton SO, Overvad K,
Redondo ML, Agudo A, Daponte A, Arriola L, Navarro C, Gurrea AB, Khaw
KT, Wareham N, Key T, Naska A, Trichopoulou A, Trichopoulos D, Masala G,
Panico S, Contiero P, Tumino R, Bueno-de-Mesquita HB, et al: Social
inequalities and mortality in Europe–results from a large multi-national
cohort. PLoS One 2012, 7(7):e39013.
28. Allebeck P, Mastekaasa A: Swedish Council on Technology Assessment in
Health Care (SBU). Chapter 5. Risk factors for sick leave - general studies.
Scand J Public Health Suppl 2004, 63:49–108.
29. Qin P, Agerbo E, Mortensen PB: Suicide risk in relation to socioeconomic,
demographic, psychiatric, and familial factors: a national register-based
study of all suicides in Denmark, 1981–1997. Am J Psychiatry 2003,
160(4):765–772.
30. Qin P, Agerbo E, Westergard-Nielsen N, Eriksson T, Mortensen PB: Gender
differences in risk factors for suicide in Denmark. Br J Psychiatry 2000,
177:546–550.
31. Beautrais AL: Suicides and serious suicide attempts: two populations or
one? Psychol Med 2001, 31(5):837–845.
32. Hawton K, van Heeringen K: Suicide. Lancet 2009, 373(9672):1372–1381.
33. Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C,
Heurgren M, Olausson PO: External review and validation of the Swedish
national inpatient register. BMC Public Health 2011, 11:450.
34. National Board of Health and Welfare: Causes of Death 2010. Västerås,
Sweden: National Board of Health and Welfare; 2010.
35. Hensing G, Alexanderson K, Allebeck P, Bjurulf P: How to measure sickness
absence? Literature review and suggestion of five basic measures.
[Review] [50 refs]. Scand J Soc Med 1998, 26(2):133–144.
36. Hensing G: Swedish Council on Technology Assessment in Health Care
(SBU). Chapter 4. Methodological aspects in sickness-absence research.
Scand J Public Health 2004, 32(63):44–48.
doi:10.1186/1471-2458-14-733
Cite this article as: Björkenstam et al.: Associations between number of
sick-leave days and future all-cause and cause-specific mortality: a
population-based cohort study. BMC Public Health 2014 14:733.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
